Works matching DE "SARS-CoV-2 Delta variant"
Results: 1782
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids.
- Published in:
- Advanced Functional Materials, 2022, v. 32, n. 39, p. 1, doi. 10.1002/adfm.202204692
- By:
- Publication type:
- Article
Cooperative and structural relationships of the trimeric Spike with infectivity and antibody escape of the strains Delta (B.1.617.2) and Omicron (BA.2, BA.5, and BQ.1).
- Published in:
- Journal of Computer-Aided Molecular Design, 2023, v. 37, n. 12, p. 585, doi. 10.1007/s10822-023-00534-0
- By:
- Publication type:
- Article
Long COVID Risk Declined Over the Pandemic: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 12
- By:
- Publication type:
- Article
Structural Basis for Evasion of New SARS-CoV-2 Variants from the Potent Virus-Neutralizing Nanobody Targeting the S-Protein Receptor-Binding Domain.
- Published in:
- Biochemistry (00062979), 2024, v. 89, n. 7, p. 1260, doi. 10.1134/S0006297924070083
- By:
- Publication type:
- Article
Comparison of the Neutralization Power of Sotrovimab Against SARS-CoV-2 Variants: Development of a Rapid Computational Method.
- Published in:
- JMIR Bioinformatics & Biotechnology, 2024, v. 5, n. 1, p. 1, doi. 10.2196/58018
- By:
- Publication type:
- Article
Correction: Mutations of SARS-CoV-2 Structural Proteins in the Alpha, Beta, Gamma, and Delta Variants: Bioinformatics Analysis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Estimate of the Basic Reproduction Number for Delta variant of SARS-CoV-2: A Systematic Review and Meta-analysis.
- Published in:
- Journal of Biostatistics & Epidemiology, 2022, v. 8, n. 1, p. 1
- By:
- Publication type:
- Article
Initiator cell death event induced by SARS-CoV-2 in the human airway epithelium.
- Published in:
- Science Immunology, 2024, v. 9, n. 97, p. 1, doi. 10.1126/sciimmunol.adn0178
- By:
- Publication type:
- Article
Impact of COVID-19 in pregnancy on maternal and perinatal outcomes during the Delta variant period: a comparison of the Delta and pre-delta time periods, 2020–2021.
- Published in:
- Maternal Health, Neonatology & Perinatology, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40748-024-00189-1
- By:
- Publication type:
- Article
Predictive Factors of Mortality in Patients with Severe COVID-19 Treated in the Intensive Care Unit: A Single-Center Study in Vietnam.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 3, p. 377, doi. 10.1007/s41030-023-00231-1
- By:
- Publication type:
- Article
Passengers screening for SARS-CoV-2 infection at Rome Fiumicino Airport: a strategy aimed at limiting the spreading of the infection through COVID-free air flights revealed the airport role as a formidable sentinel center for monitoring pandemic trends and viral variants circulation
- Published in:
- Microbiologia Medica, 2022, v. 37, n. 1, p. 1, doi. 10.4081/mm.2022.10682
- By:
- Publication type:
- Article
Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 1, p. 88, doi. 10.3390/antibiotics12010088
- By:
- Publication type:
- Article
Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 169, doi. 10.3390/vaccines13020169
- By:
- Publication type:
- Article
Effectiveness of Heterologous and Homologous Ad26.COV2.S Vaccine Boosting in Preventing COVID-19-Related Outcomes Among Individuals with a Completed Primary Vaccination Series in the United States.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 166, doi. 10.3390/vaccines13020166
- By:
- Publication type:
- Article
Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 169, doi. 10.3390/vaccines13020169
- By:
- Publication type:
- Article
Effectiveness of Heterologous and Homologous Ad26.COV2.S Vaccine Boosting in Preventing COVID-19-Related Outcomes Among Individuals with a Completed Primary Vaccination Series in the United States.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 166, doi. 10.3390/vaccines13020166
- By:
- Publication type:
- Article
Antibody Avidity Maturation Following Booster Vaccination with an Intranasal Adenovirus Salnavac Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1362, doi. 10.3390/vaccines12121362
- By:
- Publication type:
- Article
Neutralizing Antibody-Mediated Protection from Prior Delta Variant Infection Against Omicron BA.5 Sub-Lineage Reinfection One Year Later: A Prospective Cohort Study.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1211, doi. 10.3390/vaccines12111211
- By:
- Publication type:
- Article
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1152, doi. 10.3390/vaccines12101152
- By:
- Publication type:
- Article
Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 921, doi. 10.3390/vaccines12080921
- By:
- Publication type:
- Article
Equal Maintenance of Anti-SARS-CoV-2 Antibody Levels Induced by Heterologous and Homologous Regimens of the BNT162b2, ChAdOx1, CoronaVac and Ad26.COV2.S Vaccines: A Longitudinal Study Up to the 4th Dose of Booster.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 792, doi. 10.3390/vaccines12070792
- By:
- Publication type:
- Article
Immunogenicity and Protective Efficacy of a Single Intranasal Dose Vectored Vaccine Based on Sendai Virus (Moscow Strain) against SARS-CoV-2 Variant of Concern.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 783, doi. 10.3390/vaccines12070783
- By:
- Publication type:
- Article
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 505, doi. 10.3390/vaccines12050505
- By:
- Publication type:
- Article
Immunogenicity and Protective Efficacy of Psoralen-Inactivated SARS-CoV-2 Vaccine in Nonhuman Primates.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 451, doi. 10.3390/vaccines12050451
- By:
- Publication type:
- Article
Enhancement of SARS-CoV-2 mRNA Vaccine Efficacy through the Application of TMSB10 UTR for Superior Antigen Presentation and Immune Activation.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 432, doi. 10.3390/vaccines12040432
- By:
- Publication type:
- Article
Toward a SARS-CoV-2 VLP Vaccine: HBc/G as a Carrier for SARS-CoV-2 Spike RBM and Nucleocapsid Protein-Derived Peptides.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 267, doi. 10.3390/vaccines12030267
- By:
- Publication type:
- Article
High-Content Imaging-Based Assay for SARS-CoV-2-Neutralizing Antibodies.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 236, doi. 10.3390/vaccines12030236
- By:
- Publication type:
- Article
The Impact of Clinical Factors and SARS-CoV-2 Variants on Antibody Production in Vaccinated German Healthcare Professionals Infected Either with the Delta or the Omicron Variant.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 163, doi. 10.3390/vaccines12020163
- By:
- Publication type:
- Article
The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 60, doi. 10.3390/vaccines12010060
- By:
- Publication type:
- Article
The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1815, doi. 10.3390/vaccines11121815
- By:
- Publication type:
- Article
Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1786, doi. 10.3390/vaccines11121786
- By:
- Publication type:
- Article
SARS-CoV-2 Vaccine Effectiveness in Hospitalized Patients: A Multicenter Test-Negative Case–Control Study.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1779, doi. 10.3390/vaccines11121779
- By:
- Publication type:
- Article
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1557, doi. 10.3390/vaccines11101557
- By:
- Publication type:
- Article
Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12–17 Years against COVID-19 Infection in Qatar.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1522, doi. 10.3390/vaccines11101522
- By:
- Publication type:
- Article
The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1407, doi. 10.3390/vaccines11091407
- By:
- Publication type:
- Article
Unveiling Vaccine Hesitancy on Twitter: Analyzing Trends and Reasons during the Emergence of COVID-19 Delta and Omicron Variants.
- Published in:
- Vaccines, 2023, v. 11, n. 8, p. 1381, doi. 10.3390/vaccines11081381
- By:
- Publication type:
- Article
Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1234, doi. 10.3390/vaccines11071234
- By:
- Publication type:
- Article
Comparison of the Disease Severity and Outcome of Vaccinated COVID-19 Patients with Unvaccinated Patients in a Specialized COVID-19 Facility: A Retrospective Cohort Study from Karachi, Pakistan.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1178, doi. 10.3390/vaccines11071178
- By:
- Publication type:
- Article
Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants.
- Published in:
- Vaccines, 2023, v. 11, n. 6, p. 1063, doi. 10.3390/vaccines11061063
- By:
- Publication type:
- Article
Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China.
- Published in:
- Vaccines, 2023, v. 11, n. 6, p. 1019, doi. 10.3390/vaccines11061019
- By:
- Publication type:
- Article
SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 958, doi. 10.3390/vaccines11050958
- By:
- Publication type:
- Article
A SARS-CoV-2 Vaccine Designed for Manufacturability Results in Unexpected Potency and Non-Waning Humoral Response.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 832, doi. 10.3390/vaccines11040832
- By:
- Publication type:
- Article
A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies against Multiple SARS-CoV-2 Variants including the Currently Circulating Omicron BA.5, BF.7, BQ.1 and XBB.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 778, doi. 10.3390/vaccines11040778
- By:
- Publication type:
- Article
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 773, doi. 10.3390/vaccines11040773
- By:
- Publication type:
- Article
The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 764, doi. 10.3390/vaccines11040764
- By:
- Publication type:
- Article
In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 736, doi. 10.3390/vaccines11040736
- By:
- Publication type:
- Article
Mathematical Modeling Evaluates How Vaccinations Affected the Course of COVID-19 Disease Progression.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 722, doi. 10.3390/vaccines11040722
- By:
- Publication type:
- Article
Molecular Characterization and Selection of Indigenous SARS-CoV-2 Delta Variant for the Development of the First Inactivated SARS-CoV-2 Vaccine of Pakistan.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 607, doi. 10.3390/vaccines11030607
- By:
- Publication type:
- Article
Effectiveness of Inactivated Vaccine against SARS-CoV-2 Delta Variant Infection in Xiamen, China—A Test-Negative Case-Control Study.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 532, doi. 10.3390/vaccines11030532
- By:
- Publication type:
- Article